Man Group’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$436K Buy
+127,488
New +$396K ﹤0.01% 2087
2026
Q1
Sell
-38,176
Closed -$107K 2520
2025
Q4
$107K Buy
38,176
+24,069
+171% +$86K ﹤0.01% 2189
2025
Q3
$67.7K Sell
14,107
-11,140
-44% -$70.9K ﹤0.01% 2173
2025
Q2
$230K Buy
+25,247
New +$186K ﹤0.01% 2037
2022
Q4
Sell
-208,771
Closed -$5.03M 2151
2022
Q3
$5.03M Buy
+208,771
New +$6.43M 0.02% 733
2022
Q2
Sell
-163,825
Closed -$5.93M 697
2022
Q1
$7.21M Buy
163,825
+65,732
+67% +$2.82M 0.03% 741
2021
Q4
$4.27M Buy
98,093
+5,442
+6% +$213K 0.01% 934
2021
Q3
$2.9M Buy
92,651
+5,862
+7% +$231K 0.01% 1056
2021
Q2
$3.67M Buy
+86,789
New +$3.38M 0.01% 1016
2019
Q2
Sell
-59,010
Closed -$242K 1971
2019
Q1
$242K Sell
59,010
-6,229
-10% -$39.4K ﹤0.01% 1855
2018
Q4
$413K Sell
65,239
-48,805
-43% -$507K ﹤0.01% 1670
2018
Q3
$1.88M Sell
114,044
-65,109
-36% -$1.11M 0.01% 1448
2018
Q2
$2.99M Buy
179,153
+57,005
+47% +$923K 0.01% 1193
2018
Q1
$1.9M Buy
+122,148
New +$2.18M 0.01% 1304

Other funds holding ACH

Man Group's ACH Position: Q2 2026 in Review

Man Group opened a new position in Accendra Health (ACH) in Q2 2026: 127,488 shares worth $436K. The stake represents ﹤0.01% of the portfolio and ranks #2087 among its holdings. This is a return to the name: Man Group previously reported a position in ACH as recently as Q4 2025.

Man Group first reported a position in ACH in Q1 2018 and has held it in 14 quarters since. The position peaked at $7.21M in Q1 2022. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Man Group held 127,488 shares of Accendra Health worth $436K as of Q2 2026.
  • Accendra Health was a new Man Group position in Q2 2026.
  • Accendra Health made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2087 holding.
  • Man Group first reported a position in Accendra Health in Q1 2018 and has held it in 14 quarters since.
  • Man Group's Accendra Health position peaked at $7.21M in Q1 2022.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.